company background image

Radiant Innovation TPEX:3373 Stock Report

Last Price


Market Cap







24 Sep, 2022


Company Financials
3373 fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance1/6
Financial Health6/6

3373 Stock Overview

Radiant Innovation Inc. designs and develops infrared technology products.

Radiant Innovation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Radiant Innovation
Historical stock prices
Current Share PriceNT$27.20
52 Week HighNT$42.50
52 Week LowNT$18.50
1 Month Change26.22%
3 Month Change17.75%
1 Year Change-32.25%
3 Year Change58.60%
5 Year Change58.60%
Change since IPO143.16%

Recent News & Updates

Shareholder Returns

3373TW Medical EquipmentTW Market

Return vs Industry: 3373 underperformed the TW Medical Equipment industry which returned -8.9% over the past year.

Return vs Market: 3373 underperformed the TW Market which returned -17.6% over the past year.

Price Volatility

Is 3373's price volatile compared to industry and market?
3373 volatility
3373 Average Weekly Movement8.2%
Medical Equipment Industry Average Movement5.5%
Market Average Movement5.0%
10% most volatile stocks in TW Market8.2%
10% least volatile stocks in TW Market2.4%

Stable Share Price: 3373 is more volatile than 90% of TW stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: 3373's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of TW stocks.

About the Company


Radiant Innovation Inc. designs and develops infrared technology products. It offers ear and forehead thermometers, and other body temperature measurement products; and infrared precision thermometers, carbon dioxide detectors, infrared precision thermal imaging cameras, and other instruments. The company was founded in 1989 and is based in Hsinchu City, Taiwan.

Radiant Innovation Fundamentals Summary

How do Radiant Innovation's earnings and revenue compare to its market cap?
3373 fundamental statistics
Market CapNT$1.18b
Earnings (TTM)NT$24.29m
Revenue (TTM)NT$620.12m


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
3373 income statement (TTM)
Cost of RevenueNT$463.40m
Gross ProfitNT$156.72m
Other ExpensesNT$132.43m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date


Earnings per share (EPS)0.56
Gross Margin25.27%
Net Profit Margin3.92%
Debt/Equity Ratio0.0%

How did 3373 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
We’ve recently updated our valuation analysis.


Is 3373 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 2/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 3373?

Other financial metrics that can be useful for relative valuation.

3373 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.5x
Enterprise Value/EBITDA25x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 3373's PE Ratio compare to its peers?

3373 PE Ratio vs Peers
The above table shows the PE ratio for 3373 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average48.5x
1813 Polylite Taiwan
4735 AViTA
6543 Perfect Medical Industry
4155 OK Biotech
3373 Radiant Innovation

Price-To-Earnings vs Peers: 3373 is good value based on its Price-To-Earnings Ratio (48.5x) compared to the peer average (48.5x).

Price to Earnings Ratio vs Industry

How does 3373's PE Ratio compare vs other companies in the TW Medical Equipment Industry?

Price-To-Earnings vs Industry: 3373 is expensive based on its Price-To-Earnings Ratio (48.5x) compared to the TW Medical Equipment industry average (20.5x)

Price to Earnings Ratio vs Fair Ratio

What is 3373's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

3373 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio48.5x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 3373's Price-To-Earnings Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of 3373 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 3373 (NT$27.2) is trading below our estimate of fair value (NT$33.67)

Significantly Below Fair Value: 3373 is trading below fair value, but not by a significant amount.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Future Growth

How is Radiant Innovation forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score


Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Radiant Innovation has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Discover growth companies

  • Examine Radiant Innovation's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.

Past Performance

How has Radiant Innovation performed over the past 5 years?

Past Performance Score


Past Performance Score 1/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 3373 has a high level of non-cash earnings.

Growing Profit Margin: 3373's current net profit margins (3.9%) are lower than last year (17.6%).

Past Earnings Growth Analysis

Earnings Trend: 3373's earnings have grown significantly by 42.1% per year over the past 5 years.

Accelerating Growth: 3373's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 3373 had negative earnings growth (-93.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (19%).

Return on Equity

High ROE: 3373's Return on Equity (2.4%) is considered low.

Discover strong past performing companies

Financial Health

How is Radiant Innovation's financial position?

Financial Health Score


Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 3373's short term assets (NT$956.8M) exceed its short term liabilities (NT$176.0M).

Long Term Liabilities: 3373's short term assets (NT$956.8M) exceed its long term liabilities (NT$6.0M).

Debt to Equity History and Analysis

Debt Level: 3373 is debt free.

Reducing Debt: 3373 has not had any debt for past 5 years.

Debt Coverage: 3373 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 3373 has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies


What is Radiant Innovation current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 2/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 3373's dividend (5.51%) is higher than the bottom 25% of dividend payers in the TW market (2.46%).

High Dividend: 3373's dividend (5.51%) is low compared to the top 25% of dividend payers in the TW market (6.73%).

Stability and Growth of Payments

Stable Dividend: 3373's dividend payments have been volatile in the past 10 years.

Growing Dividend: 3373's dividend payments have increased over the past 10 years.

Earnings Payout to Shareholders

Earnings Coverage: With its high payout ratio (267.3%), 3373's dividend payments are not well covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: 3373 is paying a dividend but the company has no free cash flows.

Discover strong dividend paying companies


How experienced are the management team and are they aligned to shareholders interests?


Radiant Innovation has no CEO, or we have no data on them.


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Company Information

Radiant Innovation Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Radiant Innovation Inc.
  • Ticker: 3373
  • Exchange: TPEX
  • Founded: 1989
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Implied Market Cap: NT$1.177b
  • Shares outstanding: 43.29m
  • Website:


  • Radiant Innovation Inc.
  • No. 3, Industrial East 9th Road
  • 1st Floor
  • Hsinchu City
  • 300
  • Taiwan


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
3373TPEX (Taipei Exchange)YesCommon StockTWTWDOct 2004

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/09/24 00:00
End of Day Share Price2022/09/23 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.